Skip to Content

2022 UPMC Heart and Vascular Institute Heart Valve Symposium: Mitral and Tricuspid Valve Disease Section

June 23, 2022

The UPMC Heart and Vascular Institute Heart Valve Symposium is an annual CME-accredited symposium featuring a range of discussions about the latest advancements in diagnosis, treatment, and management for patients with complex valve and structural heart disease. The 2022 symposium included in-depth discussions about transcatheter aortic valve replacement (TAVR), the future of surgical aortic valve replacement, mitral and tricuspid valve disease, minimally invasive and robotic cardiac surgery, and more.

View the presentations focusing on mitral and tricuspid valve disease here.

For more information or to refer a patient, please email

Section 2: Mitral and Tricuspid Valve Disease: Moderated by Hemal Gada, MD

  • Transcatheter mitral edge-to-edge repair in low-risk patients: What are the goal posts?
  • Thinking beyond the clip – Strategies for percutaneous mitral valve replacement
  • Heart failure management in functional mitral regurgitation
  • Percutaneous tricuspid valve repair – Making it a reality
  • Challenging case deep dive: Mitral/tricuspid
    • Presented by: Amber Makani, MD
  • Embracing the robot for mitral valve surgery
  • Valve repair and replacement for endocarditis: When and how?
  • Panel discussion

View the Aortic Valve Disease session presentations here and the Structural Heart Disease session presentations here.